Skip to Main Content

Paper Details

Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.
J Med Chem
3
2022
Author NameAffiliation
Wells A MessersmithThe School of Medicine, The CU Cancer Center
Wells A MessersmithThe University of Colorado (CU) Anschutz Medical Campus (AMC) Center for Drug Discovery, The CU Cancer Center
Wells A MessersmithThe CU Cancer Center
  • 1 - 3

Datasets

Release 1.2